| Product Code: ETC9409643 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Onco-hematology Molecular Testing Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Onco-hematology Molecular Testing Market - Industry Life Cycle |
3.4 South Korea Onco-hematology Molecular Testing Market - Porter's Five Forces |
3.5 South Korea Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Type, 2021 & 2031F |
3.6 South Korea Onco-hematology Molecular Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 South Korea Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Biomarker, 2021 & 2031F |
3.8 South Korea Onco-hematology Molecular Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 South Korea Onco-hematology Molecular Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and hematological disorders in South Korea |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in molecular testing leading to more accurate and efficient diagnosis |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for molecular testing in South Korea |
4.3.2 High cost associated with onco-hematology molecular testing procedures |
4.3.3 Limited accessibility to specialized healthcare facilities in certain regions |
5 South Korea Onco-hematology Molecular Testing Market Trends |
6 South Korea Onco-hematology Molecular Testing Market, By Types |
6.1 South Korea Onco-hematology Molecular Testing Market, By Blood Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Blood Cancer Type, 2021- 2031F |
6.1.3 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021- 2031F |
6.1.4 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Myeloproliferative Neoplasms, 2021- 2031F |
6.1.5 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Myeloid Leukemia, 2021- 2031F |
6.1.6 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.2 South Korea Onco-hematology Molecular Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By qPCR, 2021- 2031F |
6.2.3 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By dPCR, 2021- 2031F |
6.2.4 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.5 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Onco-hematology Molecular Testing Market, By Blood Cancer Biomarker |
6.3.1 Overview and Analysis |
6.3.2 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By BCR-ABL1 Mbcr, 2021- 2031F |
6.3.3 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By JAK2, 2021- 2031F |
6.3.4 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By CALR, 2021- 2031F |
6.3.5 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By MPL, 2021- 2031F |
6.3.6 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By PML-RARA, 2021- 2031F |
6.3.7 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By NPM1, 2021- 2031F |
6.3.8 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.3.9 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.4 South Korea Onco-hematology Molecular Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By National Reference Lab / Specialty Lab, 2021- 2031F |
6.4.3 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By University Hospital / Oncology Center, 2021- 2031F |
6.4.4 South Korea Onco-hematology Molecular Testing Market Revenues & Volume, By Community Hospital / IDN (Regional/National), 2021- 2031F |
7 South Korea Onco-hematology Molecular Testing Market Import-Export Trade Statistics |
7.1 South Korea Onco-hematology Molecular Testing Market Export to Major Countries |
7.2 South Korea Onco-hematology Molecular Testing Market Imports from Major Countries |
8 South Korea Onco-hematology Molecular Testing Market Key Performance Indicators |
8.1 Adoption rate of molecular testing in cancer and hematological disorders treatment |
8.2 Number of clinical trials utilizing molecular testing technologies in South Korea |
8.3 Rate of incorporation of new molecular testing technologies in healthcare facilities in South Korea |
9 South Korea Onco-hematology Molecular Testing Market - Opportunity Assessment |
9.1 South Korea Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Type, 2021 & 2031F |
9.2 South Korea Onco-hematology Molecular Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 South Korea Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Biomarker, 2021 & 2031F |
9.4 South Korea Onco-hematology Molecular Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 South Korea Onco-hematology Molecular Testing Market - Competitive Landscape |
10.1 South Korea Onco-hematology Molecular Testing Market Revenue Share, By Companies, 2024 |
10.2 South Korea Onco-hematology Molecular Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here